Organic quantum dots: An ultrasmall nanoplatform for cancer theranostics

Namdev Dhas1, Monarch Pastagia2, Akanksha Sharma3

  • 1Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education (MAHE), Manipal 576104, Karnataka, India.

Insights

Quantum dots (QDs) offer a promising nanocarrier for targeted drug delivery, enhancing solubility and reducing toxicity in cancer treatment. This review explores QD applications in medicine and theranostics.

Area of Science:

  • Nanotechnology
  • Biomedical Engineering
  • Materials Science

Background:

  • Tumors are a leading global cause of death, with conventional chemotherapy causing significant toxicity.
  • Advancements allow cellular-level tumor identification and investigation of genetic variations.
  • There is a critical need for novel, targeted therapeutic technologies.

Purpose of the Study:

  • To review various types of quantum dots (QDs) used in drug delivery.
  • To discuss the chemical, physical, and manufacturing characteristics of QDs.
  • To explore the biological, medicinal, and theranostic applications of QDs.

Main Methods:

  • Review of scientific literature on quantum dots for drug delivery.
  • Analysis of QD properties including size, surface area, and charge.
  • Examination of QD manufacturing techniques.

Main Results:

  • Quantum dots (2-10 nm semiconductor particles) exhibit unique properties like precise targeting and large surface area.
  • QD-based drug carriers improve drug solubility, prolong retention time, and minimize side effects.
  • Various QD types are suitable for diverse drug administration strategies.

Conclusions:

  • Quantum dots represent a significant advancement in nanocarrier technology for drug delivery.
  • QDs offer enhanced efficacy and reduced toxicity compared to traditional chemotherapy.
  • Their versatile applications span biological, medicinal, and theranostic fields.

Related Concept Videos